SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Akums Drugs and Pharmaceuticals informs about disclosure

22 Jan 2025 Evaluate
Akums Drugs and Pharmaceuticals has informed that Income Tax Department (‘IT Department’) conducted search under the Income Tax Act, 1961 at the offices and manufacturing units of the Company and its subsidiaries. The Company has fully cooperated with the officials of IT Department during the search and responded to the clarifications and details sought by them. The company will continue to provide any further clarification/information that may be required. 

The above information is a part of company’s filings submitted to BSE.

Akums Drugs & Pharma Share Price

646.45 -4.15 (-0.64%)
08-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1887.95
Dr. Reddys Labs. 1348.70
Cipla 1431.65
Zydus Lifesciences 1149.00
Lupin 2457.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: